The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Rictor amplification to define a novel and unique subset of lung cancer patients.
Haiying Cheng
No relevant relationships to disclose
Jeffrey S. Ross
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Research Funding - Foundation Medicine
Kai Wang
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Abraham Chachoua
No relevant relationships to disclose
Xuewen Liu
No relevant relationships to disclose
Balazs Halmos
No relevant relationships to disclose
Vincent A. Miller
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Philip J. Stephens
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Roman Yelensky
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Doron Lipson
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Siraj M. Ali
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Geoff Otto
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Matthew J. Hawryluk
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Roman Perez-Soler
No relevant relationships to disclose
Bilal Piperdi
No relevant relationships to disclose